Childhood cancer is the most common cause of death from disease for children in the United States and Project:EveryChild is working to change that. Developed in partnership with the Children’s Oncology Group (COG) and funded, in part, by Rally Foundation, Project:EveryChild is focused on finding better cures for every type of childhood cancer—regardless of how
Dr. Gregory Friedman’s Immunotherapy Research for Recurrent Brain Tumors Shows Promising Preliminary Results
As a Rally Researcher and the primary investigator at the University of Alabama at Birmingham, Gregory Friedman, M.D. is devoted to studying malignant brain tumors in hopes of developing new and improved immunotherapies to treat children with recurrent tumors. One such treatment has shown promising preliminary results, and the therapy involves an unexpected source: the
In the United States, cancer is the number one disease killer of children. Yet pediatric cancer isn’t exclusive to America; it’s a global epidemic that affects more than 300,000 children around the world.
Dr. Mark Chiang Through his work at the University of Michigan Cancer Center, Rally Researcher Dr. Mark Chiang discovered a novel protein that sticks to a leukemia cancer gene called Notch. This discovery could potentially pave the way for anti-Notch drugs—drugs without the harsh, harmful side effects of traditional acute leukemia treatment. We